Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes-Reference-Cited by-同舟云学术

Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes

Published:2007-06-22 Issue:2 Volume:21 Page:159-170
ISSN:0966-0844
Container-title:BioMetals
language:en
Short-container-title:Biometals

Author:

Van Campenhout Ann,Van Campenhout Christel,Lagrou Albert,Manuel-y-Keenoy Begoña

Publisher

Springer Science and Business Media LLC

Subject

Metals and Alloys,General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Biomaterials

Link

http://link.springer.com/content/pdf/10.1007/s10534-007-9104-9.pdf

Reference48 articles.

1. Anraku M, Kitamura K, Shinohara A et al (2004) Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int 66:841–848

2. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412

3. Beutler E (1975) Reduced glutathione (GSH). In: Beutler E (ed) Red cell metabolism; a manual of biochemical methods. Grune & Stratton Inc., Orland FL, pp 131–132

4. Breuer W, Cabantchik ZI (2001) A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal Biochem 299:194–202

5. Breuer W, Ronson A, Slotki IN et al (2000) The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 95:2975–2982

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron‐carbohydrate administration;American Journal of Hematology;2023-01-09

2. Reported cardiac phenotypes in hereditary hemorrhagic telangiectasia emphasize burdens from arrhythmias, anemia and its treatments, but suggest reduced rates of myocardial infarction;International Journal of Cardiology;2016-07

3. Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?;The Laryngoscope;2016-04-23

4. Safety Issues in Iron Treatment in CKD;Seminars in Nephrology;2016-03

5. Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers*;Critical Care Medicine;2016-03